The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Chhabra Meenu since year 2005.
The trader's CIK number is 1534200.
At the time of the last reporting, Chhabra Meenu was the President and CEO of Proteostasis Therapeutics, Inc. .
(stock ticker symbol PTI).
See this page for all insider trading activities at Proteostasis Therapeutics, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2019-02-01||PTI||Proteostasis Therapeutics, Inc.||Option Ex||46,875||.00||0|
|2019-02-04||PTI||Proteostasis Therapeutics, Inc.||Sale||16,478||2.99||49,302|
|2017-12-18||PTI||Proteostasis Therapeutics, Inc.||Buy||40,000||5.00||200,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Chhabra Meenu (President and CEO of Proteostasis Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.